All research projects Auckland DHB, its patients, staff or facilities, must be approved by the Research Office as per Auckland DHB Research Policy.
The Application for approval of a Low Risk Study form [DOC, 174 KB]and Low Risk Study Approval Guide [PDF, 160 KB] are suitable for studies that are low risk for Auckland DHB in all respects and can be reviewed by an expedited pathway.
Below are the main definitions of low risk studies:
For research that is greater than low risk, and all research projects requiring a budget must be formally reviewed by the Auckland DHB Research Review Committee. Use the Application form for approval of a research project at Auckland DHB [DOC, 152 KB]. Types of research that are always considered greater than low risk are any study involving a clinical intervention or departure from normal care for patients.
Signatures can be provided either as:
If you are undertaking a review across two clear disciplines or service areas (ie, child oncology and adult oncology) then obtain signatures of both clinical directors. The signatures required reflect the service you are undertaking your research within, not the service or department you belong to.
If the principal investigator or Auckland DHB contact person is also the clinical director of the department/service where the research is to be undertaken, Section F of the form will require the signature of the person the clinical director reports to, e.g Director.
Email the Auckland DHB Application Form for Research Approval of a Low Risk Study v2 and other required documents to email@example.com or to one of the Research Office research advisors if you have been communicating directly. Your signed application form can be scanned and emailed (don't send paper copies) but for the sake of readability please also send the original Word version.
You MAY NOT START your research before you receive Auckland DHB institutional approval. If your study requires an ethical approval this must be obtained before the Auckland DHB institutional approval letter will be issued.